Search clinical trials for: PI3K inhibitor
Total 68048 results
-
Yonsei UniversityCompletedAdvanced Gastric AdenocarcinomaKorea, Republic of
-
Yonsei UniversityCompleted
-
Academisch Medisch Centrum - Universiteit van Amsterdam...CompletedMetastatic Pancreatic Cancer | Locally Advanced Pancreatic CancerNetherlands
-
SecuraBioCompletedAsthmaGermany, United Kingdom
-
SecuraBioTerminatedLymphoma | Lymphoma, Non-Hodgkin | Follicular Lymphoma | Chronic Lymphocytic Leukemia | Lymphoma, Small LymphocyticUnited States
-
Dana-Farber Cancer InstituteNovartis; AstraZenecaCompleted
-
Novartis PharmaceuticalsTerminatedRecurrent Head and Neck Squamous Cell Carcinoma | Metastatic Head and Neck Squamous Cell CarcinomaFrance, Taiwan, United States, Australia, Canada, Hong Kong, Singapore, Korea, Republic of, Netherlands
-
Novartis PharmaceuticalsCompletedMetastatic Colorectal Cancer | Gastric Cancer | Advanced Solid Tumors | Metastatic Breast Cancer | Gastroesophageal Junction Cancer | Recurrent Glioblastoma Multiforme | Advanced Pancreatic Adenocarcinoma | Safety | Triple Negative Metastatic Breast Cancer | Dose Escalation | Preliminary Efficacy | Hormone Receptor...Canada, United Kingdom, Spain, Germany, Italy, Belgium, Australia, United States
-
Novartis PharmaceuticalsCompletedAdvanced or Metastatic Breast CancerSpain, United States
-
Novartis PharmaceuticalsCompletedBreast Cancer | Solid Tumors | Cowden SyndromeUnited States, Spain, Canada
-
Novartis PharmaceuticalsCompletedRelapsed and Refractory Multiple MyelomaItaly, Germany, Singapore, Australia, United States
-
Novartis PharmaceuticalsTerminatedCutaneous Squamous Cell Carcinoma in Situ (CSCCis)Belgium, Australia, United States
-
Novartis PharmaceuticalsCompletedBreast Cancer | Advanced Solid Tumors | Cowden SyndromeNetherlands, Spain, Germany, United Kingdom, United States
-
Novartis PharmaceuticalsCompletedAdvanced and Selected Solid TumorsBelgium, Spain, Canada, Switzerland, United States
-
Novartis PharmaceuticalsCompletedMetastatic Breast Cancer (MBC) | Locally Advance Breast Cancer (LABC)United Kingdom, Spain
-
Novartis PharmaceuticalsCompletedStomach Neoplasms Esophageal Neoplasms Metastatic Gastric Cancer Mutated PI3KCA Protein Overexpressed HER2 ProteinTaiwan, Switzerland, Korea, Republic of, Germany, United States, Japan
-
Novartis PharmaceuticalsCompletedNeoplasms | Kidney Neoplasms | Breast Neoplasms | Pancreatic Neuroendocine Neoplasms (pNETs)France, Germany, United States, Netherlands, Italy, Spain, United Kingdom, Hong Kong, Hungary
-
Novartis PharmaceuticalsCompletedNeoplasms, Breast Neoplasms, Head and Neck NeoplasmsUnited States, Spain, France, Italy
-
Novartis PharmaceuticalsTerminatedMetastatic Breast Cancer (MBC) | Inoperable Locally Advanced Breast CancerFrance, Spain
-
Incyte CorporationCompletedRefractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell LymphomaUnited States
-
SOLTI Breast Cancer Research GroupDana-Farber Cancer Institute; Novartis Pharmaceuticals; Stand Up To CancerCompletedBreast CancerUnited States, Spain
-
GlaxoSmithKlineCompletedNeoplasmsUnited States, United Kingdom
-
PfizerCompletedSolid Tumor | Unspecified Adult Solid Tumor, Protocol SpecificUnited States, Australia, Canada, France, Spain
-
Array Biopharma, now a wholly owned subsidiary...CompletedAdvanced Solid Tumors | Selected Solid TumorsUnited States, Germany, Canada, Spain, Netherlands, Singapore, Switzerland
-
ArQule, Inc. (a wholly owned subsidiary of Merck...TerminatedOvarian Cancer | Endometrial Cancer | Solid TumorsUnited States
-
Novartis PharmaceuticalsCompletedBreast CancerUnited States, China, Belgium, Canada, France, Italy, Taiwan, United Kingdom, Hungary, Australia, Spain, Germany, Singapore, Austria, Japan, Israel, Russian Federation, Korea, Republic of, Thailand, Slovakia, South Africa, Switzer... and more
-
University of California, San FranciscoNovartisCompletedBRAF Mutant Metastatic MelanomaUnited States
-
Northwestern UniversityNational Cancer Institute (NCI); NovartisCompletedBYL719 + T-DM1 in HER2(+) Metastatic Breast Cancer Pts Who Progress on Prior Trastuzumab & Taxane TxHER2-positive Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
SCRI Development Innovations, LLCNovartisCompletedGlioblastoma MultiformeUnited States
-
Gilead SciencesTerminatedMantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Diffuse Large B-cell Lymphoma | Indolent Non-Hodgkin's LymphomaUnited States
-
Gilead SciencesCompletedChronic Lymphocytic LeukemiaUnited States, Hungary, Belgium, United Kingdom, France, Australia, Turkey, Croatia, Italy, Poland, Canada, Greece, Czechia, Ireland, Russian Federation, Spain, Portugal, Romania
-
Gilead SciencesTerminatedLymphoid MalignanciesNetherlands
-
Rhizen Pharmaceuticals SACompletedLymphoma, T-Cell, Cutaneous | Lymphoma, T-Cell, PeripheralUnited States
-
Novartis PharmaceuticalsBreast International Group; German Breast Group; SOLTI Breast Cancer Research...CompletedHER2-positive Newly Diagnosed, Primary Breast CancerAustria, Spain, Australia, Germany
-
TG Therapeutics, Inc.CompletedHodgkin's LymphomaUnited States
-
TG Therapeutics, Inc.CompletedChronic Lymphocytic LeukemiaUnited States
-
PIQUR Therapeutics AGRoyal Marsden NHS Foundation Trust; University College London Hospitals; Weill... and other collaboratorsCompletedLymphoma, MalignantUnited States, United Kingdom, Serbia, Bosnia and Herzegovina, France, Israel
-
Emory UniversityNovartisTerminatedRecurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic LymphomaUnited States
-
Gilead SciencesTerminatedLymphoma, Non-Hodgkin | Chronic Lymphocytic LeukemiaUnited States
-
Gilead SciencesTerminatedChronic Lymphocytic LeukemiaUnited States, France, United Kingdom, Germany, Italy
-
AstraZenecaParexelCompleted
-
Gilead SciencesCompletedFollicular Lymphoma | Marginal Zone Lymphoma | Lymphoplasmacytic Lymphoma | Small Lymphocytic LymphomaUnited States, United Kingdom, Italy, Germany, Poland, France
-
PIQUR Therapeutics AGCharite University, Berlin, Germany; University Hospital, Basel, Switzerland; University Hospital Freiburg and other collaboratorsCompletedLymphoma | Non-Hodgkin LymphomaGermany
-
Centre Leon BerardNational Cancer Institute, France; Fondation ARCCompletedHead and Neck Neoplasms | Neoplasm Metastasis | Progressive Disease | Recurrent DiseaseFrance
-
Gilead SciencesCompletedChronic Lymphocytic LeukemiaUnited States, France, United Kingdom, Germany, Italy
-
Cliniques universitaires Saint-Luc- Université...NovartisTerminatedCarcinoma Transitional CellBelgium, Luxembourg
-
PIQUR Therapeutics AGM.D. Anderson Cancer Center; Mayo Clinic; University College London Hospitals; Hospital... and other collaboratorsCompleted
-
Novartis PharmaceuticalsTerminatedMetastatic Breast CancerUnited States, Germany, Belgium, Canada, France, Italy, Spain, United Kingdom, Austria, Argentina, Sweden, Hungary, Korea, Republic of, Lebanon, Bulgaria, Greece, Thailand, Netherlands, Colombia, Norway, Finland, Poland
-
Anne ChangNovartis PharmaceuticalsTerminatedCarcinoma, Basal Cell | Skin Neoplasms | Basal Cell Nevus Syndrome | Recurrent Skin CancerUnited States